Search results

Richmond Research Institute asks the question, 'Can a second booster dose be delayed in patients who have COVID-19?'

Vaccines. 20th April 2021. Published COVID-19 Research. Richmond Research Institute is actively involved in COVID-19 symptoms testing for all staff and visitors who attempt entry to Richmond Pharmacology's London Bridge clinical trial unit.

News - Richmond Research Institute

Vaccines. Why more caution is needed in administering QT prolonging drugs to type 1 diabetic patients.

Making our local community safer by COVID-19 testing

Vaccines. Our results suggest that individuals who have previously been infected with SARS-CoV-2 achieve markedly higher antibody titres than those who have yet to show signs of infection.

A connection between SARS-CoV-2 antibodies and immunity remains uncertain

Vaccines. Antibodies. 23rd February 2021. Uncertainty remains in the connection between SARS antibodies and immunity. Our recent research findings – which concur with a.

COVID-19 Testing - Richmond Research Institute

We have also continued to test for antibodies to both infection and vaccine. By repeating these tests over time, we can establish how long the antibodies take to develop and how long immunity may last in each person.

Home video

Do post-COVID-19 patients need a second dose of vaccine? Individuals who were previously infected produced significantly more antibodies, more rapidly. This data could inform prioritisation of vaccine administration. COVID-19 Testing.

Home - Richmond Research Institute

This information could inform the prioritisation of vaccine administration. Watch the video below to learn more.

We work with partners at the following organisations: 

richmond research institute

We have a track record in conducting clinical research.


We present our scientific findings at meetings.


Our academic research helps improve lives and strengthens scientific insights.